Is elevated urine normetanephrine and norepinephrine a sign of phaeochromocytoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Elevated Urine Normetanephrine and Norepinephrine: Interpretation for Pheochromocytoma

Your results showing urine normetanephrine at 383 nmol/d (reference <281) and norepinephrine at 1145 nmol/d (reference <473) are concerning for pheochromocytoma and warrant immediate further evaluation, as these elevations are approximately 1.4-fold and 2.4-fold above the upper limit of normal, respectively. 1

Degree of Elevation and Clinical Significance

  • Your normetanephrine elevation of 1.4-fold and norepinephrine elevation of 2.4-fold place you in the "borderline to moderate" elevation category (1-4 times upper limit of normal), which requires repeat testing and potentially additional confirmatory studies. 1, 2

  • Elevations ≥4 times the upper limit of normal are highly diagnostic and warrant immediate imaging, but your levels fall below this threshold. 1, 2, 3

  • In patients with adrenal incidentalomas and borderline elevations (1-2 times upper limit), approximately 30% have confirmed pheochromocytoma on surgical pathology. 4

Recommended Diagnostic Algorithm

For levels 2-4 times upper limit of normal (which applies to your norepinephrine), repeat testing in 2 months under ideal conditions is recommended, and consider clonidine suppression testing. 1, 3

  • Plasma free metanephrines should ideally be collected from an indwelling venous catheter after lying supine for 30 minutes to minimize false positive results. 1, 2, 3

  • If plasma testing is equivocal (less than fourfold elevation), a follow-up 24-hour urine collection for catecholamines and metanephrines should be performed. 5, 1

  • The clonidine suppression test has 100% specificity and 96% sensitivity for distinguishing true pheochromocytoma from false positive results in cases of equivocal biochemical findings with strong clinical suspicion. 1, 3

Clinical Context Assessment

You must assess for hyperadrenergic symptoms including sustained or intermittent palpitations, tachycardia, diaphoresis, tremors, headaches, or new-onset hypertension, as these significantly increase the likelihood of true pheochromocytoma. 1

  • The triad of headache, palpitations, and sweating in a hypertensive patient has 93.8% specificity and 90.9% sensitivity for pheochromocytoma. 1

  • Paroxysmal hypertension with classic symptoms is a key indicator warranting immediate biochemical testing. 1

Important Caveats and Potential False Positives

  • Hypertensive patients may have elevated catecholamine metabolites, especially with obesity, obstructive sleep apnea, or use of tricyclic antidepressants. 1

  • False positive elevations are usually <4 times the upper limit of normal, which encompasses your current results. 1

  • Confirm that interfering medications and foods were avoided prior to testing, as several agents can cause false elevations. 1, 2

If Pheochromocytoma is Confirmed

If repeat testing confirms elevations ≥4 times upper limit or if you have strong clinical symptoms with persistent moderate elevations, proceed to imaging with MRI (preferred over CT due to risk of hypertensive crisis with IV contrast). 1, 2, 3

  • Never perform fine needle biopsy of a suspected pheochromocytoma before biochemical exclusion, as this can precipitate fatal hypertensive crisis. 1, 2

  • Alpha-blockade must be started 7-14 days preoperatively if pheochromocytoma is confirmed, with gradually increasing dosages until blood pressure targets are achieved. 1, 3

  • Never initiate beta-blockade alone before alpha-blockade in suspected pheochromocytoma, as this can precipitate severe hypertensive crisis due to unopposed alpha-adrenergic stimulation. 1, 2, 3

Genetic Considerations

  • Approximately 30-35% of pheochromocytomas are hereditary with autosomal dominant inheritance. 1

  • Consider genetic testing if you have family history, young age at diagnosis, bilateral disease, or extra-adrenal location. 2

References

Guideline

Diagnosis and Management of Pheochromocytoma in Hypertensive Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Suspected Pheochromocytoma/Paraganglioma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Pheochromocytoma and Paraganglioma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.